Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Quest Blog
Podcast
Product Guide
Blog Post
Blog Post
FDA Grants Orphan Drug Designation to Myonexus Therapeutics’ MYO-102 Gene Therapy Drug for Limb-Girdle Muscular Dystrophy Type 2D
By
Jeanene Swanson
|
January 4, 2019
Blog Post
FDA Announces the Approval of TIGLUTIK, an Oral Suspension Form of riluzole, for the Treatment of ALS
By
MDA Staff
|
September 10, 2018
Blog Post
From Graduation Onward: MDA National Ambassador Justin Moy Looks Ahead
By
Justin Moy
|
June 14, 2018
Blog Post
FDA Approves Radicava to Treat ALS
By
Amy Madsen
|
May 6, 2017
Blog Post
Risky Business: Nongenetic Factors May Increase Odds of Developing ALS
By
Amy Madsen
|
February 3, 2013
Blog Post
When the Thinking Parts of the Brain Go Awry in ALS
By
Amy Madsen
|
October 31, 2011
Blog Post
C9ORF72 Mutation Most Common Cause of Familial ALS, FTD, ALS-FTD
By
Amy Madsen
|
September 20, 2011
Blog Post
National ALS Registry Now Open
By
Miriam Davidson
|
October 19, 2010
Blog Post
ALS: Not Just About Motor Neurons Anymore
By
Margaret Wahl
|
April 30, 2010
Blog Post
To Cath or Not to Cath?
By
Margaret Wahl
|
February 28, 2010
« Previous
1
…
64
65
66
67
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset